The old adage is that magazine covers are a jinx. That’s particularly true with The Economist but Barron’s has had some doozies, including making the case for Pfizer earlier this year (it’s down 40% since). The cover this week certainly raised alarm bells but it may prove to be one of the better-timed calls in
